AMN AMN Healthcare Services (AMN) Insider Trading, Ownership & Congress Trades
Services · Services-help supply services · CIK 0001142750
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
182
13F, latest reported quarter
Conversions, 180 days
12
Codes C/M, not in net · $0 priced
What the filings say about AMN
Insiders, 180 days
-$114.4K net sold
1 seller · 0% of sales under a 10b5-1 plan
AMN Healthcare Services insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AMN HEALTHCARE SERVICES INC insiders sold a net $114.4K of stock across 61 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 4 earlier Form 4 trades (code P or S) here by this insider (1 buy, 3 sales), the last on Feb 29, 2024.
- The trade is 8.4% of the 19,917 shares held after it.
- No other insider sold within 30 days.
- 182 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director FOLETTA MARK G sold about $52.2K of AMN on Jun 15, 2026, the largest insider sale at the company since 2024; 182 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (1 buy, 3 sales), the last on Feb 29, 2024.
- The trade is 11.2% of the 17,917 shares held after it.
- No other insider sold within 30 days.
- 182 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director FOLETTA MARK G sold about $62.1K of AMN on Jun 15, 2026, the largest insider sale at the company since 2024; 182 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Feb 28, 2024.
- +3.1% median (+3.1% mean) 90-day return after 2 previous buys.
- The trade is 6.6% of the 37,550 shares held after it.
- No other insider sold within 30 days.
- 182 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO Knudson Jeffrey R sold about $90.8K of AMN on Nov 2, 2024; 182 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 82.1% of the 2,437 shares held after it.
- 8 other insiders bought within 30 days.
- 182 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Caballero Jorge A. bought about $113.6K of AMN on Mar 6, 2024; 8 other insiders bought within 30 days and 182 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 38.0% of the 4,558 shares held after it.
- 8 other insiders bought within 30 days.
- 182 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Fontenot Teri G. bought about $99.8K of AMN on Mar 4, 2024; 8 other insiders bought within 30 days and 182 funds added in the latest 13F quarter.61 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$114.4K over 180 days
more than 65% of Services
Congress
no House purchase disclosed in the last 12 months
Funds
182 funds bought in last quarter
more than 71% of Services
Revenue
-8.5% year over year
below 79% of Services
Margin
-3.5% net margin
below 65% of Services
Buybacks
$2.3M repurchased, FY to 2026-06-30
below 83% of Services
Short interest
9.4% of the float short (float per yahoo 2026-10-26) · 5.8 days to cover · settled 2026-09-30
more than 85% of Services
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch AMN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+134.5%12M
Insider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns AMN: institutional holders (13F)
13F holdings, latest reported quarter
6,643,401 sh
$215.0M
2,282,597 sh
$73.9M
1,719,045 sh
$55.6M
1,694,316 sh
$54.8M
1,674,561 sh
$54.2M
Congress trades in AMN
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
AMN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
AMN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Golden Eagle Dynamic Hypergrowth ETF
$2.0M position · as of 2026-06-30
2.9%
Thompson MidCap Fund
$1.6M position · as of 2026-05-31
2.5%
Pacer US Small Cap Cash Cows Growth Leaders ETF
$658.6K position · as of 2026-07-31
2.2%
Counterpoint Quantitative Equity ETF
$7.1M position · as of 2026-06-30
1.9%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.5M position · as of 2026-06-30
1.8%
Thompson LargeCap Fund
$3.7M position · as of 2026-05-31
1.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · PEO1
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2021
$9.5M
$22.5M
$3.0M
+96%
+47%
2020
$6.0M
$8.1M
$1.9M
+10%
+34%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $114.4K sold by insiders over 180 days, 182 funds added last quarter. Each figure is a federal filing, dated the day it went public.
AMN financials
Revenue growth
-8.5%
XBRL, annual
Net margin
-3.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.4B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AMN
| FY Dec 2025 | $2.7B |
| FY Dec 2024 | $3.0B |
| FY Dec 2023 | $3.8B |
| FY Dec 2022 | $5.2B |
| FY Dec 2021 | $4.0B |
| Jun 2026 | $673.2M |
| Mar 2026 | $1.4B |
| Dec 2025 | $748.2M |
| Sep 2025 | $634.5M |
| Jun 2025 | $658.2M |
| Mar 2025 | $689.5M |
| Dec 2024 | $734.7M |
| Sep 2024 | $687.5M |
At each fiscal year end
Single quarter
Net margin, TTM
+3.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AMN
| FY Dec 2025 | -3.5% |
| FY Dec 2024 | -4.9% |
| FY Dec 2023 | +5.6% |
| FY Dec 2022 | +8.5% |
| FY Dec 2021 | +8.2% |
| Jun 2026 | +3.1% |
| Mar 2026 | +4.5% |
| Dec 2025 | -1.0% |
| Sep 2025 | +4.6% |
| Jun 2025 | -17.7% |
| Mar 2025 | -0.2% |
| Dec 2024 | -25.5% |
| Sep 2024 | +1.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$439.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AMN
| FY Dec 2025 | $233.8M |
| FY Dec 2024 | $239.5M |
| FY Dec 2023 | $268.5M |
| FY Dec 2022 | $577.9M |
| FY Dec 2021 | $251.8M |
| Jun 2026 | -$198.5M |
| Mar 2026 | $555.2M |
| Dec 2025 | $67.6M |
| Sep 2025 | $14.8M |
| Jun 2025 | $68.7M |
| Mar 2025 | $82.7M |
| Dec 2024 | $56.6M |
| Sep 2024 | $47.4M |
At each fiscal year end
Single quarter
Debt to equity
1.03x
LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion); equity 2026-06-30
Debt to equity AMN
| FY Dec 2025 | 1.19x |
| FY Dec 2024 | 1.49x |
| FY Dec 2023 | 1.57x |
| FY Dec 2022 | 0.81x |
| FY Dec 2021 | 0.72x |
| Jun 2026 | 1.03x |
| Mar 2026 | 1.08x |
| Dec 2025 | 1.19x |
| Sep 2025 | 1.64x |
| Jun 2025 | 1.74x |
| Mar 2025 | 1.48x |
| Dec 2024 | 1.49x |
| Sep 2024 | 1.46x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.61x
TTM operating cash flow over LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion)
Cash flow to debt AMN
| FY Dec 2025 | 0.35x |
| FY Dec 2024 | 0.30x |
| FY Dec 2023 | 0.29x |
| FY Dec 2022 | 0.78x |
| FY Dec 2021 | 0.36x |
| Jun 2026 | 0.61x |
| Mar 2026 | 0.96x |
| Dec 2025 | 0.35x |
| Sep 2025 | 0.25x |
| Jun 2025 | 0.29x |
| Mar 2025 | 0.31x |
| Dec 2024 | 0.30x |
| Sep 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AMN
| FY Dec 2025 | -14.2% |
| FY Dec 2024 | -19.1% |
| FY Dec 2023 | +22.5% |
| FY Dec 2022 | +40.3% |
| FY Dec 2021 | +33.0% |
| Jun 2026 | +15.6% |
| Mar 2026 | -4.5% |
| Dec 2025 | -14.2% |
| Sep 2025 | -35.9% |
| Jun 2025 | -40.1% |
| Mar 2025 | -21.1% |
| Dec 2024 | -19.1% |
| Sep 2024 | +6.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AMN
| FY Dec 2025 | -4.2% |
| FY Dec 2024 | -5.5% |
| FY Dec 2023 | +7.2% |
| FY Dec 2022 | +14.8% |
| FY Dec 2021 | +11.9% |
| Jun 2026 | +4.6% |
| Mar 2026 | -1.3% |
| Dec 2025 | -4.2% |
| Sep 2025 | -11.5% |
| Jun 2025 | -12.0% |
| Mar 2025 | -6.3% |
| Dec 2024 | -5.5% |
| Sep 2024 | +2.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+10.3%
operating income after a 36.1% effective tax rate, over LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital AMN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +11.4% |
| FY Dec 2022 | +26.0% |
| FY Dec 2021 | +20.4% |
| Jun 2026 | +10.3% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +5.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.4%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed AMN
| FY Dec 2025 | -3.3% |
| FY Dec 2024 | -5.0% |
| FY Dec 2023 | +15.7% |
| FY Dec 2022 | +30.9% |
| FY Dec 2021 | +23.4% |
| Jun 2026 | +12.4% |
| Mar 2026 | +2.9% |
| Dec 2025 | -3.3% |
| Sep 2025 | -14.2% |
| Jun 2025 | -15.2% |
| Mar 2025 | -6.4% |
| Dec 2024 | -5.0% |
| Sep 2024 | +6.5% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.40x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing AMN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 14.05x |
| FY Dec 2022 | 10.42x |
| FY Dec 2021 | 17.96x |
| Jun 2026 | 12.03x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 29.85x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.2B
market value at close 2026-10-27 on 2026-08-04 shares, plus LongTermDebt as filed 2025-12-31 (6 months older than the period end) (includes the current portion), minus cash 2026-06-30
Enterprise value AMN
| FY Dec 2025 | $1.3B |
| FY Dec 2024 | $2.0B |
| FY Dec 2023 | $4.1B |
| FY Dec 2022 | $5.2B |
| FY Dec 2021 | $6.4B |
| Jun 2026 | $1.7B |
| Mar 2026 | $915.0M |
| Dec 2025 | $1.3B |
| Sep 2025 | $1.7B |
| Jun 2025 | $1.8B |
| Mar 2025 | $1.9B |
| Dec 2024 | $2.0B |
| Sep 2024 | $2.9B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+24.2%
TTM free cash flow over market value at close 2026-10-27
FCF yield AMN
| FY Dec 2025 | +38.6% |
| FY Dec 2024 | +26.3% |
| FY Dec 2023 | +9.5% |
| FY Dec 2022 | +13.0% |
| FY Dec 2021 | +4.4% |
| Jun 2026 | +35.0% |
| Mar 2026 | +99.7% |
| Dec 2025 | +38.6% |
| Sep 2025 | +30.0% |
| Jun 2025 | +32.3% |
| Mar 2025 | +27.7% |
| Dec 2024 | +26.3% |
| Sep 2024 | +6.9% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing AMN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.23x |
| FY Dec 2021 | 0.05x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $2.7B | $3.0B | $3.8B | $5.2B |
| Gross profit | $774.1M | $919.4M | $1.2B | $1.7B |
| Operating income | -$55.5M | -$102.7M | $338.4M | $647.1M |
| Net income | -$95.7M | -$147.0M | $210.7M | $444.1M |
| EPS (diluted) | -2.48 | -3.85 | 5.36 | 9.90 |
| Operating cash flow | $269.5M | $320.4M | $372.2M | $653.7M |
| Cash | $34.0M | $10.6M | $32.9M | $64.5M |
| Long-term debt | $767.1M | $1.1B | $1.3B | $843.5M |
| Buybacks | $0 | $0 | $424.7M | $576.8M |
SEC XBRL, fiscal years, as known on 2026-10-28
AMN Stock Sonar score 6/7 axes
Find similar shapesCompareAMN ranks highest on institutional and government (71st percentile) and profitability (60th), and lowest on growth (21st), among Services peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AMN filings, in plain words
Are AMN Healthcare Services insiders buying or selling AMN?
In the 180 days to 2026-10-28, AMN Healthcare Services insiders were net sellers, a net $114.4K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, AMN Healthcare Services insiders were net sellers of AMN, a net $114.4K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
